Audio gallery
2021
Immunovia reports historical breakthrough in early detection of pancreatic cancer in high risk groups – webcasted telephone conference, March 30 2021
Presentations by: Patrik Dahlen, CEO, Thomas King, MD, PhD, Linda Mellby, PhD, Immunovia
Immunovia reports positive results of the blinded clinical validation of IMMray™ PanCan-d blood test for Stage I/II pancreatic cancers in familial/hereditary risk groups in USA – and improved test performance in detecting early stage pancreatic cancer in high risk symptomatic patients.
Weblink to telephone conference and presentation – 2021-03-30
2020
Immunovia webcasted telephone conference with Patrik Dahlen, CEO, December 3 2020
Weblink to telephone conference and presentation – 2020-12-03
Patrik Dahlen, CEO Immunovia, comments on an article published on di.se on December 1 2020.
Immunovia call: Verification & Validation Update and Q&A, October 26 2020
Presenters: Mats Grahn and Patrik Dahlen
Weblink to telephone conference and presentation – 2020-10-26
Immunovia COVID-19 Update with Mats Grahn, CEO Immunovia, May 27, 2020
Weblink to telephone conference and presentation – 2020-05-27
Mats Grahn, CEO comments on the company’s COVID-19 response as well as an update on the activities in preparation for the launch of IMMray™ PanCan-d and the prospective studies
Immunovia COVID-19 Update with Mats Grahn, CEO Immunovia, May 13, 2020
Weblink to telephone conference and presentation – 2020-05-13
Mats Grahn, CEO comments on the company’s COVID-19 response as well as an update on the activities in preparation for the launch of IMMray™ PanCan-d and the prospective studies
Immunovia update call on the update on the company’s COVID-19 response with Mats Grahn, CEO Immunovia, April 1, 2020
Weblink to telephone conference and presentation – 2020-04-01
Mats Grahn, CEO comments on the company’s COVID-19 response as well as updates on the activities in preparation for the launch of IMMray™ PanCan-d and the prospective studies.
2019
Immunovia update call on the optimization study results with Mats Grahn, CEO Immunovia, June 3, 2019
Weblink to telephone conference and presentation – 2019-06-03
Audio link to telephone conference
CEO Mats Grahn comments on the optimization study results, including a slide presentation.
Immunovia Update call with Mats Grahn, CEO Immunovia, April 29, 2019
Weblink to telephone conference and presentation – 2019-04-29
Audio link to telephone conference
CEO Mats Grahn comments on the interim report for the period January-March 2019, gives an update from the Annual General Meeting on April 26 and provides additional details on the optimization work, including a slide presentation.
Telephone conference with Mats Grahn, CEO Immunovia, March 4, 2019
Link to telephone conference – 2019-03-04
2018
Telephone conference with Mats Grahn, CEO, and Laura Chirica, CCO, Immunovia, October 8, 2018
Link to telephone conference – 2018-10-08
Transcription from telephone conference – 2018-10-08
Telephone conference with Mats Grahn, CEO Immunovia, August 17, 2018
Link to telephone conference – 2018-08-17
Telephone conference with Mats Grahn, CEO Immunovia and Henrik Winther, SVP Business Development Immunovia, August 9, 2018
Link to telephone conference – 2018-08-09
Vator Pod with Mats Grahn, CEO Immunovia, May 9, 2018
In this episode of Vatorpodden Mats Grahn, CEO of Immunovia, presents how and why the company was founded, the IMMray™ technology platform for diagnosing complex diseases in a very early stage, the launch of IMMray™ PanCan-d pancreatic cancer test, commercialization and financial targets.
2017
Telephone conference with Mats Grahn, CEO Immunovia , December 20, 2017
Link to telephone conference – 2017-12-20
Telephone conference with Mats Grahn, CEO Immunovia , June 28, 2017
Link to telephone conference – 2017-06-28
Immunovia interviewed in Vetenskapsradion Sveriges Radio P1, March 28, 2017 (audio in Swedish)
“Test utvecklas för tidig upptäckt av cancer i bukspottkörteln” – 2017-03-28
“Flerfrontskrig mot cancer i bukspottkörteln” – 2017-03-28
Telephone conference with Mats Grahn, CEO Immunovia , January 17, 2017 regarding SLE study results (audio in Swedish).
Link to the telephone conference – 2017-01-17
2016
Vator Pod with Mats Grahn, CEO Immunovia, December 22, 2016, summarizing the most important events in the company in 2016 and the plans for 2017.
Telephone conference with Mats Grahn, CEO Immunovia , December 20, 2016 regarding start of prospective study PANFAM-1 (audio in Swedish).
Link to the telephone conference – 2016-12-20
Telephone conference with Mats Grahn, CEO Immunovia and Prof Carl Borrebaeck, December 15, 2016 regarding the NCI collaboration (audio in Swedish).
Link to the telephone conference – 2016-12-15
Vator Pod with Mats Grahn, CEO Immunovia and Dr. Joseph Carroll, Senior Director of Business Development & Commercialization at Knight Cancer Institute in Oregon, Portland, US, September 30, 2016
In this episode of the Vatorpod, Immunovia’s CEO Mats Grahn and Dr. Joseph Carroll, Senior Director of Business Development & Commercialization at Knight Cancer Institute in Oregon, Portland, US are being interviewed about the crucial importance of early diagnosis in cancer.
Transcript of the interview for download
Vator Pod with Mats Grahn, CEO Immunovia and Prof Carl Borrebaeck – Latest news from Immunovia presented in English, July 11 2016
Immunovia has a unique technology with which it can with a single drop of blood detect complex diseases in a very early stage. In the following podcast you can learn the Immunovia essentials and the latest impressive news:
http://www.vatorsecurities.se/pod
Vator Pod with Mats Grahn, CEO Immunovia and Prof Carl Borrebaeck, May 30, 2016
Please click on the link below to listen to Vatorpodden which features Mats Grahn, CEO Immunovia and Prof Carl Borrebaeck in an audio pod with the results from the clinical validation study with a North American sample cohort and a summary of the presentations from the WPCC and AACR Pancreatic Cancer Special Conference in Orlando FL, US, May 10-15 2016.
(Interview in Swedish)
http://www.vatorsecurities.se/pod
Vator Pod with Year-end report 2015, Feb 25, 2016
Please click on the link below to listen to Vatorpodden which features Mats Grahn, CEO Immunovia in an audio pod recorded on the 25th of February, 2016, in connection with the Year-end report 2015.
